Molecular mechanisms and therapeutic strategies of chronic renal injury: Role of rho-kinase in the development of renal injury

Journal of Pharmacological Sciences

Volumn 100, Issue 1, 2006, Pages 29-33

  Hayashi, Koichi ^a   Wakino, Shu ^a   Kanda, Takeshi ^a   Homma, Koichiro ^a   Sugano, Naoki ^a   Saruta, Takao ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Fasudil; p27kip1; Renal hemodynamics; Renal injury; Rho kinase

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ANGIOTENSIN II; CYCLIN DEPENDENT KINASE INHIBITOR 1B; FASUDIL; RHO FACTOR; RHO KINASE;

ARTERIOLE; CELL ADHESION; CELL FUNCTION; CELL MOTILITY; CELL PROLIFERATION; CELL STRUCTURE; CHRONIC KIDNEY DISEASE; DISEASE COURSE; EFFERENT NERVE; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIUM CELL; GLOMERULUS; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KIDNEY BLOOD FLOW; KIDNEY CELL; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY INTERSTITIUM; KIDNEY TUBULE CELL; MESANGIUM CELL; MOLECULAR MECHANICS; NEPHRECTOMY; NONHUMAN; PODOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENSORY NERVE; SHORT SURVEY; UPREGULATION; URETER OBSTRUCTION; VASOCONSTRICTION;

EID: 31544439891     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FMJ05003X6     Document Type: Short Survey

References (35)

1. Nobes C, Hall A. Regulation and function of the Rho subfamily of small GTPases. Curr Opin Genet Dev. 1994;4:77-81.
2. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 1997;389:990-994.
3. Narumiya S. The small GTPase Rho: cellular functions and signal transduction. J Biochem. 1996;120:215-228.
4. Shimokawa H: Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. J Cardiovasc Pharmacol. 2002;39:319-327.
5. Sawada N, Itoh H, Ueyama K, Yamashita J, Doi K, Chun TH, et al. Inhibition of rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries. Circulation. 2000;101:2030-2033.
6. Miyata K, Shimokawa H, Kandabashi T, Higo T, Morishige K, Eto Y, et al. Rho-kinase is involved in macrophage-mediated formation of coronary vascular lesions in pigs in vivo. Arterioscler Thromb Vasc Biol. 2000;20:2351-2358.
7. Wakino S, Hayashi K, Kanda T, Tatematsu S, Homma K, Yoshioka K, et al. Peroxisome proliferator-activated receptor γ ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2. Circ Res. 2004;95:e45-e55.
8. Kanda T, Hayashi K, Wakino S, Homma K, Yoshioka K, Hasegawa K, et al. Role of Rho-kinase and p27 in angiotensin II-induced vascular injury. Hypertension. 2005;45:724-729.
9. Tanaka H, Komikado C, Shimada H, Takeda K, Namekata I, Kawanishi T, et al. The R(-)-enantiomer of efonidipine blocks T-type but not L-type calcium current in guinea pig ventricular myocardium. J Pharmacol Sci. 2004;96:499-501.
10. Nakamura A, Hayashi K, Ozawa Y, Fujiwara K, Okubo K, Kanda T, et al. Vessel- and vasoconstrictor-dependent role Rho/Rho-kinase in renal microvascular tone. J Vasc Res. 2003;40:244-251.
11. Cavarape A, Endlich N, Assaloni R, Bartoli E, Steinhausen M, Parekh N, et al. Rho-kinase inhibition blunts renal vasoconstriction induced by distinct signaling pathways in vivo. J Am Soc Nephrol. 2003;13:37-45.
12. Carmines PK, Perry MD, Hazelrig JB, Navar LG. Effects of preglomerular and postglomerular vascular resistance alterations of filtration fraction. Kidney Int. 1987;31 Suppl. 20:S229-S232.
13. Anderson RJ, Ray CJ, Popoff MR. Evidence for Rho protein regulation of renal tubular epithelial cell function. Kidney Int. 2000;58:1996-2006.
14. Nakano K, Takaishi K, Kodama A, Mammoto A, Shiozaki H, Monden M, et al. Distinct actions and cooperative roles of ROCK and mDia in Rho small G protein-induced reorganization of the actin cytoskeleton in Madin-Darby canine kidney cells. Mol Biol Cell. 1999;10:2481-2491.
15. Slack JM. Epithelial metaplasia and the second anatomy. Lancet. 1986;2(8501):268-271.
16. Patel S, Takagi KI, Suzuki J, Imaizumi A, Kimura T, Mason RM, et al. RhoGTPase Activation Is a Key Step in Renal Epithelial Mesenchymal Transdifferentiation. J Am Soc Nephrol. 2005;16:1977-1984.
17. Brujin JA, Roos A, de Geus B, de Heer E. Transforming growth factor-beta and the glomerular extracellular matrix in renal pathology. J Lab Clin Med. 1994;123:34-47.
18. Hubchak SC, Runyan CE, Kreisberg JI, Schnaper HW. Cytoskeletal rearrangement and signal transduction in TGF-beta1-stimulated mesangial cell collagen accumulation. J Am Soc Nephrol. 2003;14:1969-1980.
19. Johnson RJ, Floege J, Yoshimura A, Iida H, Couser WG, Alpers CE. The activated mesangial cell: a glomerular "myofibroblasts"? J Am Soc Nephrol. 1992;2 Suppl:S190-S197.
20. Patel K, Harding P, Haney LB, Glass WF 2nd. Regulation of the mesangial cell myofibroblast phenotype by actin polymerization. J Cell Physiol. 2003;195:435-445.
21. Ingram AJ, Krepinsky JC, James L, Austin RC, Tang D, Salapatek AM, et al. Activation of mesangial cell signaling cascades in response to mechanical strain. Kidney Int. 1999;55:476-485.
22. Barisoni L, Mundel P. Podocyte biology and the emerging understanding of podocyte diseases. Am J Nephrol. 2003;23:353-360.
23. Barisoni L, Kopp JB. Update in podocyte biology: putting one's best foot forward. Curr Opin Nephrol Hypertens. 2003;12:251-258.
24. Endlich N, Kress KR, Reiser J, Uttenweiler D, Kriz W, Mundel P, et al. Podocytes respond to mechanical stress in vitro. J Am Soc Nephrol. 2001;12:413-422.
25. Heusinger-Ribeiro J, Eberlein M, Wahab NA, Goppelt-Struebe M. Expression of connective tissue growth factor in human renal fibroblasts: regulatory roles of RhoA and cAMP. J Am Soc Nephrol. 2001;12:1853-1861.
26. Nagatoya K, Moriyama T, Kawada N, Takeji M, Oseto S, Murozono T, et al. Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction. Kidney Int. 2002;61:1684-1695.
27. Satoh S, Yamaguchi T, Hitomi A, Sato N, Shiraiwa K, Ikegaki I, et al. Fasudil attenuates interstitial fibrosis in rat kidneys with unilateral ureteral obstruction. Eur J Pharmacol. 2002;455:169-174.
28. Kanda T, Wakino S, Hayashi K, Homma K, Ozawa Y, Saruta T. Effect of fasudil on Rho-kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats. Kidney Int. 2003;64:2009-2019.
29. Nishikimi T, Akimoto K, Wang X, Mori Y, Tadokoro K, Ishikawa Y, et al. Fasudil, a Rho-kinase inhibitor, attenuates glomerulosclerosis in Dahl salt-sensitive rats. J Hypertens. 2004;22:1787-1796.
30. Riser BL, Cortes P, Zhao X, Bernstein J, Dumler F, Narins RG. Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat. J Clin Invest. 1992;90:1932-1943.
31. Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest. 1986;77:1993-2000.
32. Kagami S, Border WA, Miller DE, Noble NA. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest. 1994;93:2431-2437.
33. Yamakawa T, Tanaka S, Numaguchi K, Yamakawa Y, Motley ED, Ichihara S, et al. Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells. Hypertension. 2000;35:313-318.
34. Numaguchi K, Eguchi S, Yamakawa T, Motley ED, Inagami T. Mechanotransduction of rat aortic vascular smooth muscle cells requires RhoA and intact actin filaments. Circ Res. 1999;85:5-11.
35. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol. 1981;241:F85-F93.